Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
04/30/20247:08AMAlliance NewsAlliance NewsCOMMODITIES MARKET: Oil prices slide on truce hopes; gold weaker
04/30/20247:08AMGlobeNewswire Inc.Chainswap Wins Polo Match Against Solana at Dubai's First Crypto Polo Cup Event in April 2024
04/30/20247:07AMAlliance NewsAlliance NewsIN BRIEF: Deltic Energy says Pensacola on track to be drilled in 2024LSE:DELTDeltic Energy Plc
04/30/20247:07AMBusiness WireFacteus Launches Data Sets Highlighting Consumer Cross Shopping Behavior
04/30/20247:07AMPR Newswire (Canada)Media Advisory: National report on the state of caregiving in Canada
04/30/20247:07AMPR Newswire (Canada)Hot Chili Secures Large Addition to its Costa Fuego Coastal Copper Hub in ChileTSXV:HCHHot Chili Limited
04/30/20247:07AMPR Newswire (Canada)Avis aux médias : Rapport national sur l'état de la prestation de soins au Canada
04/30/20247:07AMGlobeNewswire Inc.Tellabs Launches FlexSym OLT2: Redefining Fiber Networking for Overlay and Tactical Applications
04/30/20247:05AMGlobeNewswire Inc.SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:SOPHSophia Genetics SA
04/30/20247:05AMBusiness WireDebiopharm & Repare Therapeutics Announce First Patient Dosed in Phase 1/1b Mythic Trial Evaluating the Synthetic Lethal Combination of WEE1 AND PKMYT1 InhibitionNASDAQ:RPTXRepare Therapeutics Inc
04/30/20247:05AMGlobeNewswire Inc.Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare EpilepsyNASDAQ:HRMYHarmony Biosciences Holdings Inc
04/30/20247:05AMBusiness WireDEBIOPHARM ET REPARE THERAPEUTICS ANNONCENT LE TRAITEMENT D’UN PREMIER PATIENT DANS LE CADRE DE L’ÉTUDE DE PHASE 1/1B MYTHIC ÉVALUANT LA COMBINATION D’INHIBITEURS WEE1 ET PKMYT1 GÉNÉRANT UNE LÉTHALITÉ SYNTHÉTIQUENASDAQ:RPTXRepare Therapeutics Inc
04/30/20247:05AMGlobeNewswire Inc.Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024NASDAQ:CLSDClearside Biomedical Inc
04/30/20247:05AMBusiness WireRepare Therapeutics & Debiopharm Announce First Patient Dosed in Phase 1/1b MYTHIC Trial Evaluating the Synthetic Lethal Combination of PKMYT1 and WEE1 InhibitionNASDAQ:RPTXRepare Therapeutics Inc
04/30/20247:04AMAlliance NewsAlliance NewsLONDON MARKET MIDDAY: FTSE 100 outperforms; carmakers slide in Europe
04/30/20247:03AMAlliance NewsAlliance NewsGreatland Gold touts progress at Havieron as total development risesLSE:GGPGreatland Gold Plc
04/30/20247:03AMPR Newswire (US)HomeFront Brands sponsors Operation Homefront's Military Child of the Year
04/30/20247:02AMPR Newswire (US)ITO EN Signs MLB All Star, Shohei Ohtani, As Global Brand Ambassador for Oi Ocha
04/30/20247:02AMPR Newswire (US)Xi's visits to European countries promote healthy, stable China-EU relations
04/30/20247:01AMAlliance NewsAlliance NewsIsrael's PM Netanyahu vows to invade Rafah "with or without a deal"
04/30/20247:01AMBusiness WireStrayer University Names Dr. Antoinette ‘Toni’ Farmer-Thompson PresidentNASDAQ:STRAStrategic Education Inc
04/30/20247:00AMAlliance NewsAlliance NewsTOP NEWS: Banco Santander sees income rise in first quarterLSE:BNCBanco Santander S.a.
04/30/20247:00AMGlobeNewswire Inc.Danske Mortgage Bank Plc: Release date of Interim report H1 2024TG:A2RUPYDanske Mortgage Bank
04/30/20247:00AMGlobeNewswire Inc.PyroGenesis Kicks Off New European Distribution Strategy with Contract to Supply Spanish Aerospace Entity with Titanium Metal Powder8PY
04/30/20247:00AMGlobeNewswire Inc.Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-α-NET in NETsAMEX:CATXPerspective Therapeutics Inc
04/30/20247:00AMGlobeNewswire Inc.Climb Channel Solutions' Commitment to Excellence Recognized with Multiple Prestigious Awards in Q1 2024NASDAQ:CLMBClimb Global Solutions Inc
04/30/20247:00AMBusiness WireIncyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical ProgramsNASDAQ:INCYIncyte Corporation
04/30/20247:00AMBusiness WireOrigin Materials Partners with PackSys Global on World’s First PET Cap and Closure Manufacturing SystemNASDAQ:ORGNWOrigin Materials Inc
04/30/20247:00AMGlobeNewswire Inc.CHARM Therapeutics appoints Dr Nicholas Edmunds as Chief Development Officer, Head of Pre-Clinical Development
04/30/20247:00AMGlobeNewswire Inc.LSL Pharma Group Reports Its Fourth Quarter and Year-End 2023 Results and HighlightsTSXV:LSLLSL Pharma Group Inc